1. blackopsstreet
2. BUYtheWeak
3. sueellen
4. charmor126
5. clarkfan
1.sueellen 10/02/2017
Ignyta Announces New Data Highlighting Immuno-Oncological Efficacy of RXDX-106 at 2017 AACR Tumor Immunology and Immunotherapy Meeting
2.blackopsstreet 10/18/2017
They need to raise money for manufacturing in anticipation of approval 2018
3.BUYtheWeak 10/03/2017
I predict a partnership agreement very soon.
4.charmor126 10/18/2017
Trump killed biotech today
5.clarkfan 10/18/2017
Upped price target from 15 to 23
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW